No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
EVER EverQuote
- 25.150
- +0.930+3.84%
Close Jul 19 16:00 ET
873.34MMarket Cap-17836P/E (TTM)
25.950High24.340Low472.36KVolume24.410Open24.220Pre Close11.89MTurnover2.11%Turnover RatioLossP/E (Static)34.73MShares25.95052wk High9.89P/B564.12MFloat Cap5.36052wk Low--Dividend TTM22.43MShs Float63.440Historical High--Div YieldTTM6.65%Amplitude4.050Historical Low25.176Avg Price1Lot Size
Pre-Market
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
EverQuote, Inc. (NASDAQ:EVER) On The Verge Of Breaking Even
EverQuote, Inc. (NASDAQ:EVER) is possibly approaching a major achievement in its business, so we would like to shine some light on the company. EverQuote, Inc. operates an online marketplace for
EverQuote to Announce Second Quarter 2024 Financial Results on August 5, 2024
CAMBRIDGE, Mass., July 17, 2024 (GLOBE NEWSWIRE) -- EverQuote, Inc. (NASDAQ:EVER), a leading online insurance marketplace, today announced that it will report second quarter 2024 financial results after the market
What Makes EverQuote (EVER) a Strong Momentum Stock: Buy Now?
Director Mira Wilczek Sells 5,000 Shares of EverQuote Inc (EVER)
This Sleeper Stock Has Pushed 8 Small-Cap Funds Past the S&P 500
While FTAI may not be as glamorous as Nvidia—whose stock has surged 202% in the past year—it has benefited from the travel boom that has led to surging demand for aircraft.
Form 144 | EverQuote(EVER.US) Director Proposes to Sell 109.55K in Common Stocks
SEC FILLINGS DISCLOSED/ Jul 9, $EverQuote(EVER.US)$ Director MIRA WILCZEK intends to sell 5,000 shares of its common stock on Jul 9, with a total market value of approximately $109.55K. Source:
Comments
Investors are ignoring EverQuote's limited growth expectations, paying for exposure despite the risk. The predicted future revenues may not support a positive sentiment for long, placing investments at risk.
Risks To Shareholder Returns Are Elevated At These Prices For EverQuote, Inc. (NASDAQ:EVER)Insider sale below current stock price suggests they see this as a fair value, a potential negative signal. Ownership shows alignment between management and small shareholders, but past sales warn caution before buying.
B Riley Securities has upgraded EVER and QNST to Buy from Neutral, based on optimism about auto insurance recovery and EverQuote's cost-cutting measures, and decision to focus on core competency by leaving health insurance.
Gainers:
• $Belite Bio(BLTE.US$ +17.49% (announces that LBS-008 an orally administered tablet has been granted Fast Track Designation by the U.S. Food and Drug Administration for the treatment of STGD1)
• $Atkore(ATKR.US$ +12.11% (earnings reports)
• $AST SpaceMobile(ASTS.US$ +9.30% (receives experimental license from FCC for BlueWalker 3 satellite testing)
• $Harmonic(HLIT.US$ +7.56% (earnings reports)
• $The Chemours(CC.US$ +7.2% ...
• $Belite Bio(BLTE.US$ +17.49% (announces that LBS-008 an orally administered tablet has been granted Fast Track Designation by the U.S. Food and Drug Administration for the treatment of STGD1)
• $Atkore(ATKR.US$ +12.11% (earnings reports)
• $AST SpaceMobile(ASTS.US$ +9.30% (receives experimental license from FCC for BlueWalker 3 satellite testing)
• $Harmonic(HLIT.US$ +7.56% (earnings reports)
• $The Chemours(CC.US$ +7.2% ...
17
4
Upgrades
• $Agora(API.US$ : Morgan Stanley Upgrades to Overweight from Equalweight - PT $12.50
• $argenx SE(ARGX.US$ : Morgan Stanley Upgrades to Overweight from Equalweight - PT $375 (from $278)
• $Idacorp(IDA.US$ : Wells Fargo Upgrades to Equal Weight from Underweight - PT $110 (from $108)
• $Jakks Pacific(JAKK.US$ : BMO Capital Upgrades to Outperform from Market Perform - PT $21
• $Coca-Cola FEMSA(KOF.US$ : Barclays Upgrades to Overweight from Equal Wei...
• $Agora(API.US$ : Morgan Stanley Upgrades to Overweight from Equalweight - PT $12.50
• $argenx SE(ARGX.US$ : Morgan Stanley Upgrades to Overweight from Equalweight - PT $375 (from $278)
• $Idacorp(IDA.US$ : Wells Fargo Upgrades to Equal Weight from Underweight - PT $110 (from $108)
• $Jakks Pacific(JAKK.US$ : BMO Capital Upgrades to Outperform from Market Perform - PT $21
• $Coca-Cola FEMSA(KOF.US$ : Barclays Upgrades to Overweight from Equal Wei...
12
2
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg